SS
ABUS icon

Steve Schonfeld’s Arbutus Biopharma ABUS Stock Holding History

Steve Schonfeld’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-31,900
Closed -$61K – 2540
2022
Q3 		$61K Buy
+31,900
New +$75.1K ﹤0.01% 2614
2022
Q1 		– Sell
-12,500
Closed -$49K – 2551
2021
Q4 		$49K Sell
12,500
-133,300
-91% -$518K ﹤0.01% 1949
2021
Q3 		$626K Buy
+145,800
New +$486K 0.01% 1166
2021
Q2 		– Sell
-12,719
Closed -$42K – 1896
2021
Q1 		$42K Buy
+12,719
New +$49.1K ﹤0.01% 1726
2017
Q4 		– Sell
-125,000
Closed -$775K – 728
2017
Q3 		$775K Buy
+125,000
New +$535K 0.07% 310

Other funds holding ABUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Steve Schonfeld's ABUS Position: Q4 2022 in Review

Steve Schonfeld sold out of Arbutus Biopharma (ABUS) in Q4 2022, closing a stake of 31,900 shares — an estimated $61K sold.

Steve Schonfeld first reported a position in ABUS in Q3 2017 and held it in 5 quarters. The position peaked at $775K in Q3 2017. 114 funds tracked by Wall St. Rank hold ABUS as of Q4 2022.

  • Steve Schonfeld reported no remaining Arbutus Biopharma position as of Q4 2022 after selling out during the quarter.
  • Steve Schonfeld sold 31,900 Arbutus Biopharma shares in Q4 2022, an estimated $61K.
  • Steve Schonfeld first reported a position in Arbutus Biopharma in Q3 2017 and held it in 5 quarters.
  • Steve Schonfeld's Arbutus Biopharma position peaked at $775K in Q3 2017.
  • 114 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q4 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.